Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
814 participants
OBSERVATIONAL
2007-10-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Data collected will be the outcome measures listed above (Number of ICD-9 codes at discharge, number of CPT codes at discharge, ext)
2. In addition the total number of STICU patient-days, ventilator-days, central line-days, confirmed infectious complications, injury severity scores for trauma patients, and antibiotic-days will be collected over the three month period. This will serve as a way to ensure the observational and prospective populations are not different, and only the documentation and billing methods changed.
2. The SIC-IR billing module will be released on October 1st, 2007 after attending physician training on its use.
3. A prospective evaluation will be performed for all STICU patients over a three month time period
1. Data collected will be the outcome measures listed above (Number of ICD-9 codes at discharge, number of CPT codes at discharge, ext)
2. In addition the total number of STICU patient-days, ventilator-days, central line-days, confirmed infectious complications, injury severity scores for trauma patients, and antibiotic-days will be collected over the three month period. This will serve as a way to ensure the observational and prospective populations are not different, and only the documentation and billing methods changed.
4. After the 3 month prospective evaluation, the attending physicians will be given a survey to document their acceptance or rejection of the billing module.
5. The observational and prospective documentation and billing data will be compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Observational evaluation of current billing and documentation practices
No interventions assigned to this group
2
Use of SIC-IR Billing Module
SIC-IR Billing Module
Medical informatic application designed to help with billing and documentation within the surgical and trauma intensive care unit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SIC-IR Billing Module
Medical informatic application designed to help with billing and documentation within the surgical and trauma intensive care unit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MetroHealth Medical Center
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph F Golob, MD
Role: STUDY_DIRECTOR
MetroHealth Medical Center
Jeffrey A Claridge, MD
Role: PRINCIPAL_INVESTIGATOR
MetroHealth Medical Center
Adam MA Fadlalla, PhD
Role: STUDY_DIRECTOR
Cleveland State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MetroHealth Medical Center
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB07-00922
Identifier Type: -
Identifier Source: org_study_id